HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Mutual Fund Rank
Did you know that Zacks now ranks mutual funds? We've reinvented the way mutual funds are rated.   Try it now.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


MR: Mindray Medical Intl Ltd - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

MINDRAY MEDICAL INTL LTD (NYSE)
MR 35.96 0.85 (2.42%) Vol.  582,270 16:00 ET

Day Low - High 35.01 - 36.18
52wk Low - High 16.39 - 40.35
Avg Volume 1,045,252
Industry MED INSTRUMENTS
Market Cap 2.65 B
Div - Yield 0.20 - 0.57
PE (forward) 24.7
PEG Ratio .9
Current Year Est. 1.42
EPS Last Year 1.17
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 01/26/2010
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
MINDRAY MEDICAL INTL LTD MR PREMIUM
CANTEL MED CORP CMN PREMIUM
SONOSITE INC SONO PREMIUM
FRESENIUS MED FMS PREMIUM
See all MED INSTRUMENTS Peers

BROKERAGE RECOMMENDATIONS
Current ABR 2.10
ABR (Last Week) N/A
# of Recs in ABR 10
Average Target Price 34.57
Industry Rank by ABR 62 out of 217
Rank in Industry 32 out of 45
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate MR?
Buy
Sell
Find out what the Zacks Community
thinks of MR at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR MR
Zacks Equity Research: Report for MR
Jan 26, 2010
Zacks Blog: Mindray Beats, Affirms Guidance
Aug 11, 2009
Zacks Blog: Zacks #5 Rank Additions for Wednesday
Jul 29, 2009
Zacks Blog: Zacks #5 Rank Additions for Wednesday
Jun 24, 2009
More Zacks Commentary
NEWS
Shares of Mindray Medical International on Fire, Up 0.1% (MR)
Feb 09, 2010
SmarTrend's Trend Spotter Sees Continued Upward Momentum on Shares of Mindray Medical International (MR)
Feb 04, 2010
Health-Care Stocks Outperform Benchmarks - TheStreet.com
Jan 29, 2010
Mindray Medical International Upward Momentum Looks to Continue (MR)
Jan 27, 2010
Mindray Medical Awarded Key Software Enterprise Status for 2009 Calendar Year
Jan 22, 2010
Wall Street News Alert: Ahead of the Bell: Spine Pain Management --January 12, 2010
Jan 12, 2010
SmarTrend research report available on Mindray Medical International (NYSE:MR)
Jan 11, 2010
Mindray Medical Guides Higher
Jan 11, 2010
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 0.31 0.28 1.22 1.42
Number of Estimates 6 2 8 8
Low Estimates 0.25 0.26 1.15 1.35
High Estimate 0.36 0.30 1.32 1.57
Year Ago EPS 0.31 0.25 1.09 1.22
EPS Growth -0.54% 12.00% 11.70% 16.74%

More Estimates

COMPANY DESCRIPTION
Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has twenty nine local sales and services offices in China, as well as sales and services offices in Boston, Istanbul, London and Vancouver.

Full Company Report
FINANCIALS
EPS TTM 1.17
Sales 547.53
Net Income 133.18
Price/Earnings 30.01
Price/Book 4.44
Price/Cash Flow 18.12
Price/Sales 4.32


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research